Carmelo Ippolito

Prof. Carmelo Ippolito

Azienda Ospedaliero Universitaria di Ferrara, Italy, Ferrara, Emilia-Romagna, Italy
orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
Luca UrsoLuca Urso
Luca Urso
GRGiovanni Christian Rocca
Giovanni Christian Rocca
FBFrancesca Borgia
Francesca Borgia
FLFederica Lancia
Federica Lancia
AMAntonio Malorgio
Antonio Malorgio
MBMirco Bartolomei
Mirco Bartolomei
Initial staging of prostate cancer (PCa) is usually performed with conventional imaging (CI), involving computed tomography (CT) and bone scanning (BS). The aim of this study was to analyze the role of [18F]F-choline positron emission tomography (PET)/CT in the initial management and outcome prediction of PCa patients by analyzing data from a multidisciplinary approach. We retrospectively analyzed 82 patients who were discussed by the uro-oncology board of the University Hospital of Ferrara for primary staging newly diagnosed PCa (median age 72 (56–86) years; median baseline prostate specific antigen (PSA) equal to 8.73 ng/mL). Patients were divided into three groups based on the imaging performed: group A = only CI; group B = CI + [18F]F-choline PET/CT; group C = only [18F]F-choline PET/CT. All data on imaging findings, therapy decisions and patient outcomes were retrieved from hospital information systems. Moreover, we performed a sub-analysis of semiquantitative parameters extracted from [18F]F-choline PET/CT to search any correlation with patient outcomes. The number of patients included in each group was 35, 35 and 12, respectively. Patients with higher values of initial PSA were subjected to CI + PET/CT (p = 0.005). Moreover, the use of [18F]F-choline PET/CT was more frequent in patients with higher Gleason score (GS) or ISUP grade (p = 0.013). The type of treatment performed (surgery n = 33; radiation therapy n = 22; surveillance n = 6; multimodality therapy n = 6; systemic therapy n = 13; not available n = 2) did not show any relationship with the modality adopted to stage the disease. [18F]F-choline PET/CT induced a change of planned therapy in 5/35 patients in group B (14.3%). Moreover, patients investigated with [18F]F-choline PET/CT alone demonstrated longer biochemical recurrence (BCR)-free survival (30.8 months) in comparison to patients of groups A and B (15.5 and 23.5 months, respectively, p = 0.006), probably due to a more accurate selection of primary treatment. Finally, total lesion choline kinase activity (TLCKA) of the primary lesion, calculated by multiplying metabolic tumor volume and mean standardized uptake value (SUVmean), was able to more effectively discriminate patients who had recurrence after therapy compared to those without (p = 0.03). In our real-world experience [18F]F-choline PET/CT as a tool for the initial management of PCa had a relevant impact in terms of therapy selection and was associated with longer BCR-free survival. Moreover, TLCKA of the primary lesion looks a promising parameter for predicting recurrence after curative therapy.
1

1 September 1998 in International Urology and Nephrology
Verified
Journal Article
Closed access
PDF file
MCM. Cecchi
M. Cecchi
RMR. Minervini
R. Minervini
CSC. A. Sepich
C. A. Sepich
CICarmelo Ippolito
Carmelo Ippolito
GPG. L. Pagni
G. L. Pagni
LFL. Fiorentini
L. Fiorentini

Verified
Journal Article
Open access
PDF file
CBChiara Borghi
Chiara Borghi
MMMargherita Manservigi
Margherita Manservigi
EMElena Sofia Milandri
Elena Sofia Milandri
CICarmelo Ippolito
Carmelo Ippolito
PGPantaleo Greco
Pantaleo Greco
LDLUCIO DELL'ATTI
LUCIO DELL'ATTI
Objective: To review the literature on the impact on female quality of life and sexual function of orthotopic reconstruction after radical cystectomy for non-malignant bladder conditions. Radical cystectomy is commonly required to treat malignant conditions but may also be considered for the treatment of non-malignant diseases. These heterogeneous group of disorders includes interstitial cystitis, painful bladder syndrome, neurogenic bladder, haemorrhagic/ radiation cystitis, endometriosis and refractory genitourinary fistula. Treatment begins with non-invasive medical therapies but, in non-responder cases, a surgical solution should be considered. Such invasive techniques include urinary diversion and reconstructive procedures that have an impact on healthrelated quality of life, physical, social, and mental status. Materials and methods: This narrative review research was done using the PubMed database up until 2020, July. All papers referring to cystectomy for benign indication were considered. Results: In comparison to other reconstructive options, orthotopic neobladder allows the restoration of a normal self-image and consequently it is the most suitable procedure when a surgical reconstruction is necessary for non-malignant conditions. However, women can face many disorders that impact on everyday life, such as voiding dysfunction or sexual activity problems. Conclusions: Scant data is available about quality of life, sexual life and self-perception in women treated by cystectomy for benign conditions and most literature is dedicated to those indicators in cancer patients. More research is needed to understand the tolerability and the quality of life results of the female population affected by benign conditions undergoing this kind of surgical approach.

24 April 2023 in Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
Luca UrsoLuca Urso
Luca Urso
GRGiovanni Christian Rocca
Giovanni Christian Rocca
GCGrazia Maria Conti
Grazia Maria Conti
ACAlessandro Colella
Alessandro Colella
ANAlberto Nieri
Alberto Nieri
MBMirco Bartolomei
Mirco Bartolomei